GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.
Pharma major GlaxoSmithKline and software giant Tata Consultancy Services on Tuesday signed a 'multi-year, multi-million dollar' contract to set up a global drug development support centre in Mumbai.
Health drinks such as Ribena, Lucozade and X-35 Body fuel may soon become the household names, as PepsiCo, Coca-Cola, Amul and GlaxoSmithkline are planning to introduce these drinks.
Ranbaxy Laboratories has reached an agreement with GlaxoSmithKline on the litigation over the patent validity of GSK's anti-viral drug Valtrex (Valacyclovir Hydrochloride).
GlaxoSmithKline Plc has withdrawn its patent application in India for anti-AIDS drug Combivir, which has been facing opposition from activists.
The Delhi high court had earlier allowed Indian pharma major Wockhardt to sell its Ace Proxyvon tablets, which is a mixture of three salts -- aceclofenac, paracetamol and rabeprazol -- a combination that is banned.
Businesses across the world consider efficient delivery of shipments to be a growth driver, and IoT-based start-up Roambee fills this need with real-time reports to businesses using tracking data.
Foreign multinational drug makers, barring GlaxoSmithKline Pharmaceuticals, continue to have a miniscule presence in the domestic market even after the product patent regime came into being.
GlaxoSmithKline Pharmaceuticals Limited is expanding its clinical trial data management, analyses and reporting activities in India where it plans to double the headcount depending on business needs.
Having moved into original research, they have attracted overseas professionals looking to come back, some nudged by MNCs' narrowing research.
The government on Wednesday said Indian drug makers Ranbaxy and Cipla have approached it for assistance in manufacturing Tamiflu to fight bird flu
Names such as Danone, Dabur, Mondelez and Abbott Healthcare have also figured on the list of suitors.
Adani Exports and GlaxoSmithKline Consumer were the only two A-group stocks that ended in the positive territory.
Most foreign drug makers have 100% subsidiaries in India, apart from their listed arms.
The organisers of the men's tour will unveil a partnership deal with a pharmaceutical giant on Tuesday to provide approved nutritional supplements to players next season.\n
SAS, global leaders in business intelligence solutions, on Friday announced setting up of its largest research and development centre in Pune, as it expects the Indian market to grow by 27 per cent and generate $87.4 billion worth business by 2009.
Ranbaxy Laboratories on Monday said it has received final approval from the United States Food and Drugs Administration to manufacture and market Amoxicillin and Clavulnate Potassium tablets, a generic version of GlaxoSmithkline's Augmentin.
Take the Rediff Business Quiz and see if you know which are the world's top steel, pharma, wine comapnies.
India's Supreme Court in April rejected a patent for Novartis AG's cancer drug Glivec, saying it was an amended version of a known molecule called imatinib, setting the precedent for more such cases in the country.
GlaxoSmithKline Consumer Healthcare on Thursday launched a new, sugar-free, low calorie avtar of its flagship brand Horlicks for health conscious adults.
Take the Rediff Biz Quiz and find out how much you know about Indian malted beverages.
GlaxoSmithKline plc, Europe's biggest drugmaker, said on Wednesday that it was accelerating work on a possible vaccine against the deadly SARS virus but warned development would take years.
Ranbaxy Laboratories Ltd, India's top drugmaker by sales, said it expected to get US approvals for a paediatric dosage of its generic version of Augmentin, GlaxoSmithKline's blockbuster antibiotic, within a month.\n\n\n\n
The much-awaited merger of Burroughs Wellcome India Ltd with GlaxoSmithKline Pharmaceuticals Ltd in the country was approved by boards of both entities on Wednesday with a swap ratio of 14:10 shares.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances